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Abstract
We assess patients admitted to English obstetrics departments to identify what proportion of variation
in their costs is explained by patient characteristics and what proportion is due to departmental
characteristics. Hospital Episode Statistics records for every patient admitted to obstetrics
departments are matched to Reference Cost data by HRG reported by all English hospitals for the
year 2005/6. Our sample consists of 951,277 patients in 136 departments. We estimate fixed effects
models analysing patient-level costs, explore departmental characteristics that drive variation in costs
at department-level and explore the sensitivity of results to the use of the full sample and sub-samples
of obstetrics patients. Patient costs depend on various diagnostic characteristics over and above the
HRG classification, particularly whether the patient suffered infection. After controlling for patient
characteristics a substantial amount of unexplained variation in costs remains at departmental level.
Higher costs are evident in departments that are not supported by a neonatology specialty and where
factor prices are higher. There is evidence of lower costs in departments with high volumes of activity.
We identify departments where further scrutiny of their high costs is required.
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1. Introduction
It is often asserted that health care organisations face limited competitive pressures that would
otherwise encourage them to innovate and adopt cost minimising behaviour. Competitive behaviour
may be less in evidence if health care is publicly funded or in situations where organisations enjoy a
geographical or specialist monopoly of supply (Bilodeau et al., 2000). When competitive pressure is
weak, there may be scope for better utilisation of resources and reductions in cost. But in the absence
of competition, pressure to reduce costs must come from another source, such as a regulatory
authority or policy-maker. In this context, information on the performance of the health care
organizations assumes a key role allowing the policy maker to compensate the absence of
competitive markets with correct regulation policies.
There have been numerous studies that examine hospital costs or efficiency (Worthington, 2004,
Hollingsworth, 2008, Rosko and Mutter, 2008). Yet despite this proliferation of academic research, it
has had limited influence on regulatory policy and its impact on hospital behaviour has been
negligible. We contend that this is because comparative analysis of hospitals suffers two drawbacks.
First it is very difficult for analysts to make any clear recommendations as to where practical efforts
should be directed should one hospital be found more costly or less efficient than another. Hospitals
are multi-product organisations and, to take action, management needs to know whether poor
performance is a problem in general or is limited to specific product lines. By considering the hospital
as a whole, most studies offer limited insight into the source of higher costs or apparent inefficiency.
The second related, but more fundamental, limitation is that it cannot be assumed that a common
production function applies across all hospitals. Indeed the majority of hospitals, particularly non-
specialist hospitals, house a range of different departments or specialties, each of which can be
considered as having a distinct production function. It is difficult to capture these distinctive features in
hospital-level analysis, especially when hospitals are quite heterogeneous with respect to their
specialty mix. Any failure to observe and control for this heterogeneity will bias the comparative
assessment.
In previous work it has been argued that specialty-level analysis is preferable to hospital-level analysis
(Harper et al., 2001). This is because each particular specialty is more likely to be undertaking
comparable activities, treating similar types of patients and, hence, applying a production technology
similar to that in the same specialty in other hospitals. Thus comparing the same specialty across
hospitals is more appropriate for both analytical purposes and for informing policy-makers and
practitioners about how to respond to the findings. However, research based on specialty-level
analysis is uncommon because routine data are rarely available at this level. In this paper, we seek to
overcome this drawback by exploiting patient-level data, recognising that patients are clustered within
specialties.
The use of patient-level data offers an additional important advantage. In all probability the primary
reason why costs vary among hospitals/specialties is because each treats a different mix of patients.
Most studies make allowance for expected differences in care requirements by differentiating patients
using Diagnosis Related Groups (DRGs) or variants thereof such as the Healthcare Resource Groups
(HRGs) used in England. However the classification system used to differentiate between patients
can never account for all cost variation. This would not be a problem if differences across providers
were random, where it is a matter of chance whether any particular patient is more or less expensive
than the average patient in the HRG to which they are classified. With sufficiently large volumes,
these differences cancel out. Problems arise if the differences across providers are systematic, with
one type of provider more likely to treat low-cost patients and another treating more high-cost
patients. For example, teaching hospitals might attract more severe patients within the same HRG
categories as compared with other hospitals because of their excellence in providing such treatments;
or hospitals located in deprived areas might serve more complex case-mix of patients because of the
lower health status of people living in these areas. By using patient-level data, we are able to control
for various personal and diagnostic characteristics over and above the HRG to which the patient is
allocated when making comparisons of specialty costs, thereby making inferences about performance
more robust (Jacobs et al., 2006, Hauck and Street, 2006, Olsen and Street, 2008).
We focus on all obstetrics specialties in England to assess what explains variation in the unit costs of
the patients they treat using data for every patient discharged from an obstetrics department during
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2005/06. We assess two main questions. Firstly, to what extent are costs explained by the
characteristics of patients admitted to obstetrics departments? Secondly, after controlling for patient
characteristics, why do some obstetrics departments have higher costs than others? We describe our
data in section two, including how we have matched data from different sources. Our econometric
approach is described in section three, followed by results in section four. We draw conclusions in
section five.
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2. Data
We analyse the hospital episode statistics (HES) for all patients discharged from an English obstetrics
department in 2005/6. HES comprise individual patient records – defined as a Finished Consultant
Episode (FCE) – about every NHS patient treated as a day case or inpatient in England. Each patient
record contains socio-demographic (e.g. age, gender, average income in their area of residence) and
clinical information (e.g. diagnoses, procedures performed).
We focus on obstetrics departments for two main reasons. First, there is a limited set of HRGs to
which obstetrics patients are allocated: the majority (96%) of activity is confined to twelve HRGs
(chapter N, comprising neonatal, maternity and antenatal care). Compared to specialties that treat a
more diverse set of patients, this should ensure limited heterogeneity in the production process
across obstetrics departments. Second, most patients admitted to obstetrics remain under the care of
a single consultant during their hospital stay, meaning that activity in obstetrics departments is
reasonably self-contained, with patients rarely being transferred to other consultants/specialties. 98%
of FCEs in obstetrics are single episode spells, compared to 79% for all HES records (Castelli et al.,
2008). This helps ensure that the costs of care are borne solely and fully by the obstetrics
department, rather than reflecting joint production with other departments.
From an initial sample of 1,009,747 obstetrics patients our analytical sample is reduced to 951,277
after dropping patients for the reasons detailed in Appendix 1. Each patient record in HES is mapped
to cost information supplied by every English hospital according to the process detailed in Appendix 2.
This mapping procedure allows us to obtain variation in the cost of treating patients within their HRG
classification in each department. Additional variation comes from the method of admission and the
excess daily cost identifiable for those with long lengths of stay. For obstetrics departments, variation
in patient level cost is illustrated in Figure 1, where each vertical set of points shows the cost of all
patients in each obstetrics department. Cost variation is also evident when considering a single HRG,
as Figure 2 shows for normal deliveries. Table 1 shows the distribution of activity in obstetrics
departments according to HRGs in the N chapter, together with summaries of length of stay and cost.
Figure 1: Patient costs by obstetrics department, all obstetrics patients
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Figure 2: Patient costs by obstetrics department, normal deliveries only
Table 1 Activity in obstetrics departments, by HRG
HRG Patients
% of all
obstetrics
patients
% long
stay
patients Cost Mean Cost SD
N01 Neonates - Died <2 days old 252 0.0% 0.0% 716 329
N02
Neonates with Multiple Minor
Diagnoses 972 0.1% 0.3% 1,091 201
N03
Neonates with one Minor
Diagnosis 6,236 0.7% 0.9% 763 176
N04
Neonates with Multiple Major
Diagnoses 30 0.0% 0.0% 830 1,082
N05
Neonates with one Major
Diagnosis 184 0.0% 0.0% 777 713
N06 Normal Delivery w cc 20,847 2.2% 4.1% 1,831 765
N07 Normal Delivery w/o cc 251,360 26.4% 20.2% 1,126 526
N08 Assisted Delivery w cc 5,916 0.6% 5.0% 2,240 907
N09 Assisted Delivery w/o cc 50,597 5.3% 4.1% 1,483 463
N10 Caesarean Section w cc 19,072 2.0% 7.4% 3,366 1,310
N11 Caesarean Section w/o cc 97,547 10.2% 5.8% 2,350 834
N12
Antenatal Admissions not
Related to Delivery Event 464,972 48.8% 11.5% 647 461
Total N 917,985 96.4% 12.5% 1,100 854
Other All other HRGs 34,292 3.6% 7.4% 779 623
Total 952,277 100.0% 12.3% 1,088 849
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3. Methods
Our main objective is to analyse the variation in costs across departments after taking account of
differences in the patients they treat and external factors that might affect departmental costs but that
are beyond their control. To do this, we perform a two stage analysis. First we regress patient level
costs against a set of patient characteristics that might explain their costs and a departmental fixed
effect. From this equation we obtain each department’s average cost purged of the influence of the
characteristics of their patients. Second we investigate variations in average cost that persist at
departmental level using an Estimated Dependent Variable model (EDV).
In the first stage we estimate a fixed effects model of the following form:
ij h ij k ij q ij d ij j ijc u vc c c c     ȕ K ȕ N ȕ T ȕ G (1)
where
ij
c is the cost for patient i in department j .1 ijh is a vector of dummy variables specifying the
HRG to which the patient is allocated, with the HRG for a normal delivery (N07) being the reference
category2; ijk is vector of variables capturing age and an index of income deprivation of the area
where the patient lives; ijq is a vector of variables specific to obstetrics care, including the number of
babies delivered, birth weight, and whether or not the baby was still-born; and ijd is a vector
diagnostic and procedural variables, including counts of diagnoses and operations performed and
dummy variables which capture diagnostic characteristics of patients that might explain costs over
and above the HRG to which the patient is allocated. These dummy variables are identified by
examining the frequency of diagnoses recorded across the diagnostic fields for all the patients in the
sample. Table 2 reports the ICD-10 codes used to construct these variables and the number of
obstetrics and maternity patients to which they apply.
This equation is estimated for four different samples of patients as a form of sensitivity analysis. The
first sample includes all patients admitted to the obstetrics department, the second includes only
patients with a length of stay below their HRG-specific trimpoint (trimmed sample), the third includes
only patients with a length of stay above their trimpoint (long-stay sample), and the fourth considers
only patients receiving maternity care, these being patients allocated to HRGs N06-N11. This analysis
allows us to assess if our predictions are sensitive to length of stay outliers, how representative
maternity patients are of obstetrics patients in general and whether conclusions about costs across
departments are sensitive to what activity is considered. Descriptive details of the explanatory
variables for the patients included in each equation are shown in Table 3.
From equation (1) we obtain Ö
j
u , the departmental fixed effect, which can be interpreted as a measure
of relative departmental performance after allowing for differences in patient characteristics (Hauck et
al., 2003, Bhalotra and Zamora, 2008). Its values express the difference between the average unit
cost of a specific department and the population average. Thus, positive values indicate that the
average cost per patient in the department in question is above the average.
1 Although there is evidence of heteroscedasticity in patient costs, transforming costs into logarithmic form is not required to our
analysis. OLS provides consistent estimates of departmental fixed effects which are the main objective of our analysis in the
first stage. Using log transformation may improve the estimation of the SE, but will result in estimated coefficients based on
geometric rather than arithmetic mean. Retransforming such coefficients is not straightforward in the presence of
heteroscedasticity (Manning, 1998). We obtain consistent SE by applying the cluster robust estimator.
2 Rather than dummy variables, it is common to construct a casemix index to capture cost variation across HRGs. Construction
requires attaching a resource weight to each HRG to allow aggregation. In this study, the relatively small number of HRGs and
large sample size allow us to avoid making assumption about HRG relative weights and, instead, estimate these from the data.
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Table 2 Obstetrics patients with particular diagnostic markers
Label ICD-10 diagnosis codes All obstetrics patients Maternity patients
Pre-eclampsia and eclampsia O14.0-O15.9 14,335 1.51% 9,124 2.05%
Haemorrhage O2O.8 O20.9 O44.1 O46 O67 O72 O03-6.1&6 74,946 7.88% 42,220 9.51%
Diabetes O24 R81 E1 17,995 1.89% 9,395 2.12%
Infection O23 O44.1 O75.3 O86 R50 J22.X O03-6.0&5 27,258 2.87% 8,709 1.96%
Hypertension O16 O11 I10 28,089 2.95% 8,551 1.93%
Obesity E66 2,002 0.21% 947 0.21%
Smoker Z72.0 19,597 2.06% 14,142 3.18%
Lifestyle risk factors Z72.1 Z72.2 Z72.4&8&9 Z35.7 Z86.4 Z91.5 Z86.5 9,568 1.01% 6,406 1.44%
Abortion O01 O02 O03 O04 O05 O06 O07 O08 7,408 0.78% 407 0.09%
Allergy Z88 15,041 1.58% 10,150 2.29%
Past history of disease Z85 Z86.0&1&2&3&6&7 Z87.4 8,556 0.90% 5,777 1.30%
Complications in past pregnancy Z87.5 Z87.6 2,785 0.29% 1,804 0.41%
Perineal laceration O70.2 O70.3 93,873 9.87% 93,386 21.03%
Table 3 Descriptive statistics
All obstetrics patients Obstetrics patients - trimmed sample Obstetrics patients - long stay sample All maternity patients
mean Std_dev mean Std_dev mean Std_dev mean Std_dev
Cost 1088 849 1025 726 1538 1368 1578 915
Age 28.09 6.92 28.07 6.96 28.25 6.63 28.82 6.42
Income index 0.177 0.134 0.176 0.134 0.182 0.136 0.170 0.132
# babies 0.405 0.509 0.399 0.507 0.453 0.523 0.840 0.416
Birth weight (1000g) 1.174 1.630 1.165 1.633 1.232 1.604 2.432 1.562
Delivered dead 0.002 0.043 0.002 0.043 0.002 0.045 0.004 0.060
# operations 1.120 1.429 1.079 1.398 1.412 1.604 2.348 1.212
# diagnoses 2.294 1.432 2.256 1.409 2.563 1.556 3.165 1.411
Pre/eclampsia 0.015 0.122 0.011 0.105 0.043 0.202 0.021 0.142
Haemorrhage 0.079 0.270 0.074 0.262 0.116 0.320 0.096 0.294
Diabetes 0.019 0.136 0.018 0.132 0.028 0.164 0.021 0.144
Infection 0.029 0.167 0.023 0.151 0.066 0.249 0.019 0.138
Hypertension 0.030 0.169 0.029 0.167 0.035 0.184 0.019 0.137
Obesity 0.002 0.046 0.002 0.046 0.002 0.040 0.002 0.046
Smoker 0.021 0.142 0.021 0.142 0.021 0.144 0.032 0.175
Lifestyle risk factors 0.010 0.100 0.010 0.097 0.013 0.115 0.014 0.119
Abortion 0.008 0.088 0.007 0.086 0.010 0.100 0.001 0.030
Allergy 0.016 0.125 0.016 0.124 0.017 0.129 0.023 0.149
Past disease 0.009 0.094 0.009 0.093 0.011 0.105 0.013 0.113
Comps in past pregnancy 0.003 0.054 0.003 0.054 0.003 0.050 0.004 0.064
Perineal laceration 0.099 0.298 0.092 0.289 0.148 0.355 0.210 0.407
Observations 952,273 834,847 117,426 445,339
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Note that these fixed effects are not equivalent to the efficiency estimates derived from applying
cross-sectional stochastic frontier models, for which a second-stage analysis is inappropriate. This is
because stochastic frontier models rely on estimation of an efficiency frontier in relation to which each
organisation’s efficiency is measured. This means that efficiency estimates are not independent
observations, thereby invalidating the standard assumptions for regression analysis (Simar and
Wilson, 2004). Instead, we avoid estimating a frontier and exploit the multi-level structure of our data
to extract independently distributed departmental fixed effects
While differential efficiency (or effort) is unobservable, observable factors driving residual variation in
costs across departments can be explored. To this end, the departmental fixed effects estimated in
the first stage are regressed against a set of departmental variables in a second stage regression of
the form:
0 1
Ö
j j x j ju zG G Xc   į [ (2)
where jx is a vector of variables capturing departmental characteristics, summarised in Table 4. This
includes the number of patients treated, insurance contributions per birth3 and the number of staff
employed.4 We also include variables describing the hospital in which the department is located,
including whether it has a teaching function, a neonatology department operating alongside the
obstetric department as a distinct unit, and how many sites the obstetrics department is split over, if
any. We also consider the quality of clinical coding by measuring what proportion of the hospital’s
total caseload cannot be apportioned to any HRG.
Table 4 Departmental descriptive statistics
mean Std_dev
Number of patients (100s) 70.02 41.03
Insurance per birth (£) 545.15 17.08
Staff 99.64 48.39
Teaching status 0.15 0.36
Neonatology dept 0.51 0.50
Total sites 1.15 0.50
Coding quality (%) 1.18 1.97
Input price index (x100) 112.40 8.60
Departments 136
Arguably all the variables included in
j
x are within the control of the department, if only in the short
run. Hospitals have (at least some) discretion about their scale of operation, their staffing
complements, and the hospital’s configuration. They are also able to influence their insurance
contributions to some extent by improving their risk management strategies. While these variables
might explain variation in costs, they do not represent differing exogenous or environmental cost
constraints and, as such, it would not be legitimate to control for these factors in a performance
analysis.
However, English hospitals have limited ability to control some of their costs. The fundamental
reason is that they cannot locate where they wish – public hospitals are charged with serving their
3 Insurance contributions form a significant proportion of costs incurred in obstetrics departments
(http://www.timesonline.co.uk/tol/life_and_style/health/article5168353.ece accessed 17/11/08). Each department’s contribution
is based on staffing levels, number of births, claims history and risk management strategies (Fothergill, personal
communication)
http://www.nhsla.com/NR/rdonlyres/8A429D32-B5F2-41CE-A60F-087775DA28DC/0/NHSLAFactsheet5200506.xls
accessed 11/11/08
4 We measure the number of whole time equivalent obstetricians, gynaecologists and midwives per 100 patients, as reported to
the NHS Litigation Authority. This index weighs staff of different types according to their respective wages.
http://www.ic.nhs.uk/webfiles/publications/esr_earnings_2007-7/July%202007%20Earnings%20Estimates%20Tables.pdf
accessed 27/11/08
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local population and they cannot simply chose to relocate to another part of the country where
circumstances may be more favourable. In effect, hospitals face locational constraints that impact on
their production costs and that are outside their control. In equation (2) these constraints are captured
by the variable jz that captures differences in the labour and capital factor prices faced by providers
in different parts of England as measured by an input price index (the so-called Market Forces Factor
(MFF)) (Mason et al., 2009).
In order to provide a picture of the obstetrics departments’ relative performance, we estimate the
variation in their average costs after controlling for their patient characteristics and exogenous factor
prices. This can be easily achieved by indirect standardization techniques:
Ö Ö Ö
j
is z
j j
u u u  (3)
0 1
Ö Ö ÖÖ
j
z
j x ju zG G c  į [ (4)
where Ö
j
u is obtained from equation (1) and jxx is the vector of variables in equation (2) set to their
mean. These variable are not used for standardization but, instead, are included in order to avoid
omitted variable problem that arises if factor prices, jz , are correlated with jx (O'Donnell et al.,
2008). Finally,
1
ÖG and Ö xcį are parameters estimated from equation (2).
We interpret Ö
j
isu as a measure of relative departmental performance in controlling costs, purged of the
effect of the factor prices they face and the characteristics of their patients.
The two stage model described here is based on two main assumptions about the data generating
process (DGP) that determines the observed cost, input, case-mix and environmental variables in the
obstetrics departments. First, our model assumes a separability condition between environmental
factors, case-mix and the inputs in the cost function of the obstetrics departments. This allows us to
purge the influence of case-mix and factor prices from the departmental average cost. This is similar
to the assumption proposed in Simar and Wilson on the DGP that describes the relationship between
production function, environmental factors and efficiency (Simar and Wilson, 2004).
Second, we assume that the obstetrics departments share the same cost function. This allows us to
describe how departmental level variables influence department costs in the second stage and is
required in order to identify what factors are responsible for the variation in average costs across
departments. This assumption is generally unrealistic for analysis at hospital level given the
multiproduct nature of hospital activity. But we argue that the activity of hospital departments, such as
obstetrics, is more homogeneous and, consequently, can be realistically considered as determined by
the same underling production process.
The two-stage model we have specified borrows from the literature on EDV models that are widely
applied in political analysis studies. Jusko and Shively and Lewis and Linzer discuss extensively the
hypothesis under which EDV models involving a two stage approach are consistent and efficient
(Jusko and Shively, 2005, Lewis and Linzer, 2005). In particular, heteroscedastic sampling errors in
the estimated dependent variables might result in biased standard errors in the second stage
analysis. Efron robust SE estimators are adopted, which are known to provide a suitable solution
under this hypothesis5.
Note also that the potential gains in efficiency from estimating a two-stage model in a single stage are
modest when considerable information is available at the bottom level (Lewis and Linzer, 2005). In
our study we have almost one million observations at patient level, with each department having no
less than one thousand observations. This makes our two-stage procedure a valid approach to the
analysis.
5 While the Breush-Pagan test for test for heteroshedasticity is negative in the second stage model (equation 2) this is known to
be not completely reliable in small samples (Long and Ervin, 2005). Therefore, we elect to apply Efron standard errors.
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4. Results
4.1 Patient-level costs
Estimation results are presented in Table 5. Results for the full sample of obstetrics patients appear
first, with the model explaining 55% of the variation in patient costs (R-sq overall=0.5514). The first
set of variables show the estimated cost for each HRG relative to the cost of a normal delivery, after
conditioning on the other covariates. For maternity HRGs the estimates are little different to the mean
costs (compared to a normal delivery) reported in Table 1. Most of the neonatal HRGs are not
statistically significant, reflecting the relatively low number of observations in these HRGs. The main
reason is that neonatal care, particularly for more complex patients, is mainly managed by
neonatology departments.
Estimates from the full sample show that costs are driven by patients characteristics over and above
their HRG classification. In particular, pre-eclampsia/eclampsia and infections explain an economically
relevant portion of the average cost of patients treated in obstetrics. Other important health conditions
associated with high cost are diabetes and total number of diagnosis and operations performed.
Interestingly, the socioeconomic status of the patients is associated with higher costs, a finding in line
with evidence about the relationship between socioeconomic deprivation of the patient treated and the
cost of treatment (Cookson and Laudicella, 2009). Conversely some patient conditions are associated
with lower costs, the most economically relevant being the occurrence of abortion.
Results derived from estimating the equation on the trimmed and long stay samples are then
presented. For the trimmed sample, the patient’s HRG is the most important predictor of variation in
costs while additional patient characteristics are generally not significant. An exception is patients that
underwent an abortion who typically have lower costs. In contrast, it appears that patients who stay
beyond their HRG trimpoint do so for good reason, with many of the diagnostic characteristics over
and above their HRG being significant explanators of cost both statistically and economically. This
finding supports the use of extra payments for patients who stay beyond the trimpoint as it suggests
that the HRG alone is not sufficient to account for cost variations among long-stay patients.
The final set of estimates in Table 5 presents results when considering maternity patients only (i.e.,
patients assigned to HRGs N06-N11). Results are broadly similar to those for all obstetrics patients,
unsurprisingly given that maternity patients comprise 47% of the total. But there are some notable
differences. The baby’s weight and mother’s smoking behaviour are associated with lower costs. The
former is an indicator of baby and mother’s health, while the latter reflects the circumstance that
mothers in better health are less likely to quit smoking during pregnancy, as shown in the economic
literature (Rosenzweig and Schultz, 1983). Finally, it is notable that the occurrence of an infection is
by far the most relevant determinant of high costs in maternity care, patients suffering infections
costing £300 more to care for than those who do not. Table 3 shows that 2% of maternity patients are
at risk of infections. Particularly if contracted after admission, investment in efforts to reduce the risk of
infection might generate substantial cost savings.
4.2 Estimation and comparison of department effects
The primary purpose of the patient-level equations is to control for a broad range of patient
characteristics when assessing variation in average costs across obstetrics departments. After taking
these patient characteristics into account, there remains a high degree of unexplained variation in the
average cost per patient across departments, as indicated by the value of rho in Table 5. When
considering all obstetrics patients, 19% of the variation in costs is explained at department level rather
than due to observed characteristics of the patients within departments. For patients discharged
before the trimpoint, there is a high proportion of variance in costs between departments (rho=42%).
Departmental variance in costs is less evident when considering those with longer lengths of stay
(rho=8%). This is largely due to the greater variation in costs for patients who stay beyond the
trimpoints, for whom we are able to attribute per diem estimates of the long-stay costs.
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Table 5 First stage estimates
coeff se t coeff se t coeff se t coeff se t
Neonates - Died <2 days old -279.19 107.21 -2.60 -254.59 108.19 -2.35 (dropped)
Neonates with Multiple Minor Diagnoses 237.34 116.17 2.04 328.25 108.01 3.04 -66.01 47.83 -1.38
Neonates with one Minor Diagnosis -184.02 100.08 -1.84 -105.17 83.86 -1.25 -414.22 212.30 -1.95
Neonates with Multiple Major Diagnoses -186.20 419.53 -0.44 39.48 394.64 0.10 (dropped)
Neonates with one Major Diagnosis -215.25 219.76 -0.98 -60.47 184.70 -0.33 (dropped)
Normal Delivery w cc 681.00 72.74 9.36 784.68 74.30 10.56 1627.34 97.23 16.74 636.67 64.38 9.89
Assisted Delivery w cc 1023.30 59.96 17.07 1173.00 64.19 18.27 1959.98 137.48 14.26 990.87 51.82 19.12
Assisted Delivery w/o cc 308.75 19.09 16.18 424.30 19.38 21.89 624.24 40.83 15.29 316.33 18.91 16.73
Caesarean Section w cc 2119.47 74.40 28.49 2201.20 74.44 29.57 3567.02 108.67 32.83 2070.30 75.21 27.53
Caesarean Section w/o cc 1192.64 52.35 22.78 1253.90 52.22 24.01 1883.36 68.02 27.69 1191.64 52.11 22.87
Antenatal Admissions -303.82 38.92 -7.81 -321.03 37.82 -8.49 -360.25 39.30 -9.17
General Abdominal Disorders <70 w/o cc -170.30 72.90 -2.34 -123.76 70.50 -1.76 -93.26 257.91 -0.36
Examination, Follow up and Special Screening -338.14 58.46 -5.78 -324.99 56.24 -5.78 -490.77 65.43 -7.50
Upper Genital Tract Minor Procedures 87.37 112.01 0.78 130.91 123.78 1.06 -193.13 103.68 -1.86
Medical Termination of Pregnancy -56.83 42.94 -1.32 -7.55 36.90 -0.20 -235.39 89.09 -2.64
Treatment of Fibroids, Menstrual Disorders, or Endometriosis -253.08 49.81 -5.08 -226.43 47.14 -4.80 503.12 583.88 0.86
All other HRGs -1.75 59.06 -0.03 31.29 60.17 0.52 646.17 144.14 4.48
Age -1.31 1.24 -1.05 1.02 1.36 0.75 -3.64 3.04 -1.20 -3.43 1.66 -2.06
Age^2 0.04 0.02 1.93 -0.02 0.02 -0.63 0.15 0.06 2.70 0.08 0.03 2.66
Income index 36.18 8.56 4.23 14.14 5.88 2.41 12.24 32.43 0.38 33.47 10.51 3.19
# babies 72.98 36.35 2.01 -14.05 32.93 -0.43 148.49 45.98 3.23 119.90 20.88 5.74
Birth weight -14.37 12.56 -1.14 17.77 11.77 1.51 -69.54 17.39 -4.00 -53.76 5.29 -10.17
Delivered dead -26.71 52.67 -0.51 -11.16 45.66 -0.24 41.48 104.76 0.40 -55.07 36.06 -1.53
# operations 34.87 7.72 4.52 19.81 8.06 2.46 -4.68 7.28 -0.64 19.07 3.92 4.87
# diagnoses 24.69 5.57 4.43 -0.98 5.57 -0.18 50.68 6.60 7.68 22.61 3.20 7.07
Pre/eclampsia 299.40 20.94 14.30 2.61 9.84 0.26 308.23 31.87 9.67 359.27 26.60 13.50
Haemorrhage 21.25 12.88 1.65 -22.62 12.71 -1.78 39.01 14.82 2.63 51.25 15.06 3.40
Diabetes 51.40 14.45 3.56 4.07 19.01 0.21 72.89 24.44 2.98 75.98 13.08 5.81
Infection 185.45 16.59 11.18 11.56 9.41 1.23 253.97 25.09 10.12 303.26 27.67 10.96
Hypertension 17.24 13.97 1.23 -18.72 12.84 -1.46 31.35 30.58 1.03 40.66 26.58 1.53
Obesity -56.16 29.90 -1.88 -3.27 26.59 -0.12 -1.61 107.74 -0.01 7.83 36.27 0.22
Smoker 15.62 24.12 0.65 36.51 23.06 1.58 73.22 38.77 1.89 -38.71 10.12 -3.82
Lifestyle risk factors -16.86 25.78 -0.65 -31.56 25.08 -1.26 58.65 35.89 1.63 21.06 11.79 1.79
Abortion -160.11 36.25 -4.42 -210.61 32.89 -6.40 -135.99 65.29 -2.08 64.45 38.04 1.69
Allergy -51.23 14.02 -3.65 -12.38 13.37 -0.93 -112.54 24.79 -4.54 -33.41 6.67 -5.01
Past disease -15.46 12.80 -1.21 -11.92 10.42 -1.14 -13.37 32.59 -0.41 -4.55 8.37 -0.54
Comps in past pregnancy -62.98 33.37 -1.89 -30.91 36.31 -0.85 -54.90 60.07 -0.91 -37.10 22.05 -1.68
Perineal laceration -41.06 8.39 -4.89 -12.91 8.38 -1.54 -105.49 10.99 -9.60 -30.64 5.64 -5.43
Constant 917.46 36.50 25.13 901.48 37.70 23.91 1388.56 55.44 25.05 1077.45 31.23 34.50
Sigma_u 250.31 237.58 346.27 362.03
Sigma_e 524.21 278.82 1127.89 573.82
Rho 0.1857 0.4206 0.0861 0.2847
R-sq within 0.5675 0.8246 0.2821 0.5444
R-sq between 0.5161 0.5446 0.0855 0.0558
R-sq overall 0.5514 0.7694 0.2693 0.4739
Patients 952,273 834,847 117,426 445,339
Departments 136 136 136 136
All obstetrics patients Obstetrics patients - trimmed
sample
Obstetrics patients - long stay
sample All maternity patients
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In our second stage analysis, we consider what influence departmental characteristics has over
variance in Ö
j
u . The fixed effects from estimating equation (1) for all obstetrics patients are highly
correlated with those from the trimmed sample (r=0.98) while the correlation is lower when compared
to fixed effects from the long-stay and maternity samples (r=0.83 and r=0.87 respectively).
Table 6 reports results from the model in equation (2) according to the sample of patients considered.
There is some evidence of lower costs in obstetrics departments with higher volumes of activity,
although this effect is not statistically significant when considering any of the sub-samples of patients.
Costs are also lower in the obstetrics department if the hospital has a separate neonatology unit,
probably because more expensive neonatal care can be delivered there instead of in the obstetrics
department. Finally, higher average costs are evident in departments that face higher input prices,
although the effect is not significant in the maternity sample. No other variables are significant
explanators of the variation in departmental costs.
After controlling for differences among departments in the type of patients they treat and in the factor
prices they face by applying equation (3), we rank departments according to their average costs and
report the 95% confidence intervals around their mean. Figure 3 shows that departmental ordering is
similar if the analysis is based on the full sample of obstetrics patients or limited to only those patients
discharged before the trimpoint. This is due to the fact that the patients included in the latter sample
represent 88% of the full sample. The ordering is more sensitive to whether analysis is restricted to
long-stay patients (Figure 4) or maternity patients (Figure 5). However, re-ranking occurs mainly in the
middle of the distribution. At the extremes, identification of those departments with the lowest and
highest costs is not sensitive to what sample of patients is considered.
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Figure 3 Departmental rankings from analysis of all obstetrics patients and trimmed sample
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Table 6 Results of second stage estimates
All obstetrics patients Obstetrics patients - trimmed sample Obstetrics patients - long stay sample All maternity patients
coeff se t coeff se t coeff se t coeff se t
Number of patients (000s) -1.58 0.66 -2.39 -1.21 0.63 -1.93 -1.65 1.03 -1.60 -1.75 1.17 -1.50
Insurance per birth (£) 0.83 1.32 0.63 1.01 1.33 0.76 0.37 1.50 0.25 1.81 2.01 0.90
Staff 0.72 0.44 1.64 0.62 0.42 1.49 0.68 0.69 0.98 1.31 0.88 1.48
Teaching status -65.54 53.77 -1.22 -90.65 52.04 -1.74 -7.35 73.46 -0.10 -5.69 97.65 -0.06
Neonatology dept -111.23 42.71 -2.60 -99.51 40.44 -2.46 -158.55 63.05 -2.51 -160.57 64.70 -2.48
Total sites 50.64 46.88 1.08 42.65 41.32 1.03 86.24 92.39 0.93 37.60 53.63 0.70
Coding quality -3.50 9.95 -0.35 -2.49 9.43 -0.26 -17.37 14.66 -1.19 -1.68 16.58 -0.10
Input price index (x100) 7.03 2.71 2.59 6.32 2.53 2.50 9.39 4.23 2.22 5.49 4.57 1.20
Constant -1153.94 815.46 -1.42 -1186.50 809.43 -1.47 -1208.04 1071.64 -1.13 -1564.25 1304.47 -1.20
R-sq 0.19
136
0.17
136
0.17
136
0.11
136Departments
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Figure 4 Departmental rankings from analysis of all obstetrics patients and long-stay sample
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Figure 5 Departmental rankings from analysis of all obstetrics patients and maternity patients
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5. Conclusions
By using patient-level data our analysis offers several contributions over other approaches to
consideration of hospital costs or efficiency. The first advantage is that the researcher is not restricted
to consideration of the hospital as the unit of analysis but can undertake specialty-level analysis. The
latter are often more homogeneous units that can be assumed to be subject to a common production
function. One of the main analytical problems with analysing hospitals is that each comprises a
diverse range of specialties and any failure to account for the heterogeneous mixture of production
functions within and across hospitals will undermine the comparative exercise.
Second, we provide more insight into why costs vary from one patient to another, since we are able to
account for a much broader range of patient characteristics than simply the HRG to which the patient
is allocated. As would be expected, the patient’s HRG is the most significant explanatory variable but
diagnostic markers over and above the HRG, are significant. Perhaps of most interest is that patients
suffering an infection have substantially higher costs. These costs might be avoided if the risk of
infection could be reduced.
Diagnostic characteristics are particularly important in explaining the variation in cost, particularly
among long-stay and maternity patients. Our finding provides support for the policy of extra-payments
for length of stay outliers (Department of Health, 2009) as well as for policy enlarging the varieties of
HRGs available. The new version 4 HRGs, which have recently been developed, may be more
successful at capturing variation in costs among maternity patients, for example. Compared to the
version 3.5 HRGs used in this study, the number of maternity HRGs in version 4 has expanded from
six to nine and an age split (at 18 years) has been introduced.
Third, the multilevel structure of patient-level data enables us to obtain a departmental fixed effect
without resorting to stochastic frontier methods under a cross-sectional framework. Thus, we are not
forced to make assumptions about the production or cost frontier and are able to investigate
variations in our fixed effects in a second-stage analysis – a process that would be suspect if
analysing variation in non-independently distributed efficiency estimates (Wang and Schmidt, 2002,
Simar and Wilson, 2004). We control for the diverse characteristics of each department’s patients by
washing out this important influence on costs, then we provide a second-stage analysis of
departmental fixed effects. After taking account of these patient characteristics, substantial variation in
the average cost per patient persists across departments. Higher average costs are evident in smaller
obstetrics departments, those in hospitals that lack a separate neonatology department and where
factor prices (as measured by MFF) are higher. The fact that insurance contributions are not
significant in explaining variations in costs among departments is reassuring, as it suggests that the
burden of these premiums is similar across departments.
Obstetric departments are ranked according to their average costs purged of heterogeneity in patient
characteristics and factor prices. The relative rank of most departments varies according to the
subsample of patients considered: all obstetrics patients, patients discharged prior to the trimpoint or
long-stay patients, and maternity patients. At the extremes of the distribution, though, the relative
position of the lowest and highest cost departments remains unchanged.
Although we have controlled for an extensive set of patient characteristics and differences in factor
prices in our analysis, there may be further explanations as to why costs vary across departments that
our analysis has been unable to account for. One possibility is that hospitals differ in their coding
practice, to the extent that some provide better coded HES data than others. Our variable measuring
coding quality was not significant however. Another possibility is that hospitals assess their costs in
different ways, with differences likely to stem from how they have decided to apportion shared
resources, such as doctors working across specialties, or hospital overheads, even though the
Department of Health give detailed guidelines on common accountancy practice to be adopted. While
this apportionment is problematic whatever costing system is in place (Jackson, 2001), it may have
less impact in obstetrics departments, these being relatively self-contained, than for specialties that
are more inter-linked with others. A further reason why costs might differ, of course, is that some
obstetrics are simply better organised and more efficient than others. Ultimately determining the
remaining reasons why some obstetrics departments have such high costs is properly the
responsibility of hospital management and our analysis identifies those obstetrics departments where
managerial effort is most required.
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Appendix 1: Starting and analytical samples
We apply standard criteria to identify duplicate records in HES (Castelli et al., 2008). This provides us
with a starting sample of 1,009,747 FCEs. As Table A1 shows, a number of records were dropped
from the analysis for the following reasons.
x We omit eight hospitals where fewer than 1,000 FCEs are recorded in the obstetrics
department.6 1,125 FCEs are dropped because of this.
x Two hospitals did not use the obstetrics specialty code when making their Reference Cost
returns, making it impossible to match their HES and cost data. Three other hospitals failed to
report costs for a high proportion of the HRGs to which their patients were allocated. These
five hospitals are excluded, meaning that 30,895 patients are dropped from the analysis.7
x For 13,063 patients, there was no corresponding reference cost reported by the patient’s
hospital for the HRG to which they were allocated, meaning that a cost could not be assigned
to them. These losses were not at random being concentrated among a selective set of
hospitals.8
x FCEs assigned to “U” HRG codes are dropped, of which there were 12,014.
x A small number of obstetrics patients are recorded as having invalid or very long lengths of
stay. Some of these values may be due to errors in recording either the date of admission or
date of discharge, although some may be genuine values. Conservatively we have decided to
drop patients with a length of stay of more 100 days. This means dropping 133 records.
x Finally, we exclude 260 observations with a cost in excess of £15,000.
Table A1 Starting and analytical samples
observations %
Starting sample 1,009,747 100.00%
Drop activity in low volume NHS hospitals 1,125 0.1%
Drop hospitals that did not assign obstetrics specialty code in
their Reference Cost return or that had low volumes after
matching 30,875 3.1%
Drop activity where that could not be matched to Reference
Cost data 13,063 1.3%
Drop activity assigned to U code HRGs 12,014 1.2%
Drop FCEs with LoS more than 100 days 133 0.0%
Drop FCEs with cost more than £25,000 260 0.0%
Sample for analysis 951,277 94.3%
6 RC1 Bedford Hospital NHS Trust (18 FCEs), RD1 Royal United Hospital Bath NHS Trust (50), RDZ The Royal Bournemouth
And Christchurch Hospitals NHS Foundation Trust (9), RG3 Bromley Hospitals NHS Trust (97), RLN City Hospitals Sunderland
NHS Foundation Trust (547), RN7 Dartford And Gravesham NHS Trust (124), RNH Newham University Hospital NHS Trust
(277), RXW Shrewsbury And Telford Hospital NHS Trust (3)
7 RG2 Queen Elizabeth Hospital NHS Trust (11,676 FCEs), RJ1 Guy's And St Thomas' NHS Foundation Trust (5,354), RAJ
Southend University Hospital NHS Foundation Trust (10,590). RBZ Northern Devon Healthcare NHS Trust (1,297), RNJ Barts
And The London NHS Trust (1,998).
8 Some departments have a minimal number of obstetrics patients assigned to a diverse range of HRGs. Examples are RGQ
Ipswich Hospital NHS Trust (where 1,214 FCEs are allocated to 27 HRGs for which costs are not reported); RQM Chelsea And
Westminster Hospital NHS Foundation Trust (849 FCEs, 63 HRGs).
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Appendix 2: Assigning reference costs to individual HES records
To assess the costs of patient care we use the Reference Cost database, which is a unique
international resource. England is unusual in having made it mandatory for all NHS hospitals to report
costs for the patients they treat. In no other country are disaggregated cost data routinely available for
all providers, even where hospitals are paid on the basis of their activity (Schreyögg et al., 2006). This
means that analysis of hospital costs in other countries is always based on either a limited sample of
hospitals or utilises data reported at hospital level, such as total expenditure. In England, the
Reference Costs form the basis for calculating the national tariff, according to which hospitals are paid
under Payment by Results (PbR). To our knowledge, no research has exploited the original data
provided by each hospital (although work has been based on cost data aggregated to HRGs or by
hospital).
Hospitals in England do not collect detailed information on each patient’s resource use that would
allow bottom-up costing of patient care. Rather, every hospital applies a standard top-down costing
methodology to produce a Reference Cost for each elective, day case and non-elective HRG in each
specialty. This means that total hospital costs are progressively cascaded down first to treatment
services (wards, theatres, pharmacy, etc), then to specialties, and finally to HRGs. Reference Costs
are calculated on a full absorption basis, meaning that they should reflect the full and true cost of the
service delivered (Department of Health, 2008).
In making their Reference Cost returns hospitals report five pieces of cost information for each HRG
(h) in each of their specialties. So, for any given obstetrics department, j, the following will be
reported:
x Average cost per day case in HRG h: dhjc
x Average cost for elective patients in HRG h with a length of stay below HRG-specific trimpoint
value: ehjc
x Excess per diem cost for an elective patient in HRG h who stays in hospital beyond the HRG-
specific trimpoint: ehjex
x Average cost for non-elective patients in HRG h with a length of stay below HRG-specific
trimpoint value: nhjc
x Excess per diem cost for a non-elective patient in HRG h who stays in hospital beyond the
HRG-specific trimpoint nhjex
Trimpoints are defined for length of stay outliers in each HRG according to whether the patient was
admitted as an elective or non-elective. We define e
h
t as the elective trimpoint in days and n
h
t as the
nonelective trimpoint for HRG h.9
The Reference Cost information provided by each hospital is assigned to each patient record in HES,
according to the type of admission and how long each patient stays in hospital, as follows:
x If the patient was treated as a day case d dihj hjif a co
x If the patient was an elective with length of stay at or below the elective trimpoint
( , )
e e e
ihj ihj h hjif a L t cd o
x If the patient was an elective with length of stay above the elective trimpoint
( , ) ( )
e e e e e
ihj ihj h hj hj ihj h
if a L t c ex L tª º! o  u ¬ ¼
9 Trimpoints are revised periodically by the Information Centre. We have applied the trimpoints that were published alongside
the national tariff for 2005/6
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4091529 accessed 15/9/08
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x If the patient was non-elective (including maternity, baby or a transfer) with length of stay at or
below the non-elective trimpoint ( , )n nihj ihj h hjif a L t cd o
x If the patient was a non-elective (including maternity baby or a transfer) with length of stay
above the non-elective trimpoint ( , ) ( )e n n n n
ihj ihj h hj hj ihj h
if a L t c ex L tª º! o  u ¬ ¼
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